# Study maps enzyme target for potential treatment of rare genetic disorder

> Researchers at the Icahn School of Medicine at Mount Sinai mapped the AASS enzyme, a target for treating glutaric aciduria type 1, a rare inherited metabolic disorder. The findings were published in the November 13 issue of Science Advances and reveal how the enzyme's activity is regulated.

- Date: 2026-11-14 · published 2026-11-14T06:09:58.000Z
- Category: report · region US · magnitude low
- Page: https://feedsoft.ai/events/99044-study-maps-enzyme-target-for-potential-treatment-of-rare-genetic-disorder
- Commodities: [Lysine](https://feedsoft.ai/c/LYSINE.md)

## Why it matters

This is a human medical research study with no plausible effect on feed supply, demand or prices for animal-feed buyers.

## Sources

- news-medical.net: https://www.news-medical.net/news/20261113/Study-maps-enzyme-target-for-potential-treatment-of-rare-genetic-disorder.aspx

---
Data from Feedsoft AI (https://feedsoft.ai/). For information only; not investment advice.